How Migraine Medications Are Tested
Posted on December 10 2024,
Stay in the Loop on the Latest in Migraine:
1. Testing Immediate Relief Medications (Acute Treatment)
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| How Often Patients Need to Have Migraine Attacks to Join the Study | 1-6 migraine attacks per month | 2-8 migraine attacks per month, <15 headache days |
| How Success is Measured (primary endpoint) |
Whether migraine attack resolved at 2 hours |
Whether pain is completely gone at 2 hours AND most bothersome symptom |
| Additional Success Measures | Just pain relief | • Complete pain relief • Relief from most bothersome symptom • Whether relief lasts for 24-48 hours |
| Side Effect Tracking | Basic tracking | Detailed reporting of all side effects |
2. Testing Preventive Medications
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| Who Can Participate | People with 2-6 migraine attacks monthly | People with up to 15 migraine attacks monthly |
| How Success is Measured (primary endpoint) | Counting fewer attacks | Either: • Fewer migraine attack days per month • At least 50% reduction in migraine days (should be the secondary endpoint, if not the primary) |
3. Special Cases
For People with Chronic Migraine
| What's Important | Details |
|---|---|
| Who Can Participate | People can be included even if they have medication overuse/adaptation headache |
| Success Measures (primary endpoint) | Reduction in number of moderate/severe headache days |
| Additional Benefits (secondary endpoint) | Whether migraine attacks become less frequent overall (conversion to episodic migraine) |
For Children and Adolescents
| What's Important | Details |
|---|---|
| Age Groups | Ages 6-17 allowed to participate |
| Special Requirements | • Must have had migraine attacks for at least 6 months • Parents can help report symptoms • Studies must run year-round (not just during school) |
For Migraine with Visual/Sensory/Speech or Language Symptoms (Aura)
| What's Important | Details |
|---|---|
| Minimum Requirement | At least one migraine with aura monthly |
| Success Measures | • How often auras occur (primary endpoint) • How often headaches follow the aura (secondary endpoint) |
Wed, Jan 14, 26
New Emergency Department Migraine Treatment Guidelines
The American Headache Society (AHS) has released its 2025 guideline update for the acute treatment of migraine in adults presenting to the emergency department. This update, published in Headache in...
Read MoreSun, Jan 04, 26
Long-Term Safety of Anti-CGRP Monoclonal Antibodies
A comprehensive meta-analysis of over 4,300 patients reveals that erenumab, galcanezumab, fremanezumab, and eptinezumab maintain good tolerability beyond 12 months. Only 3% of patients stopped treatment due to adverse events,...
Read MoreThu, Jan 01, 26
Alternate Nostril Breathing Protocol for Migraine
Alternate nostril breathing is a simple yogic technique that's showing real promise for migraine prevention. Unlike acute treatments, this practice builds nervous system resilience over time - making attacks less...
Read More